Maloman E N, Syrbu V T, Lupashku B K
Antibiotiki. 1975 Jun;20(7):613-7.
The results of the studies on the effect of chemotripsin on the antimicrobial activity of monomycin against laboratory cultures, such as Staph. aureus 209 P, E. coli M38 and Streptococcus zymogenes and 20 clinical strains isolated from patients with purulent peritonitis are presented. The studies were performed with the method of two-fold serial dilutions. It was found that chemotripsin decreased 3.2.10-2.6.10(5) times the MIC (minimum inhibitory concentration) and the bactericidal concentration of monomycin. The presence of fibrin in the medium inhibited 4-128 times the antibacterial effect of monomycin. The potentiating effect of chemotripsin on monomycin could be explained by both a better "contact" of the antibiotic with the microbes and an direct increase in the antibiotic sensitivity of the microbial cells. Combination of monomycin with chemotripsin provided the use of decreased doses of the antibiotic. It is an effective means of overcoming the antibiotic resistance in pathogenic microbes.
本文介绍了关于化学胰蛋白酶对单霉素针对实验室培养菌(如金黄色葡萄球菌209P、大肠杆菌M38和发酵链球菌)以及从化脓性腹膜炎患者分离出的20株临床菌株抗菌活性影响的研究结果。研究采用了两倍系列稀释法。结果发现,化学胰蛋白酶使单霉素的最低抑菌浓度(MIC)和杀菌浓度降低了3.2×10至2.6×10⁵倍。培养基中纤维蛋白的存在使单霉素的抗菌效果降低了4至128倍。化学胰蛋白酶对单霉素的增效作用可通过抗生素与微生物更好的“接触”以及微生物细胞对抗生素敏感性的直接提高来解释。单霉素与化学胰蛋白酶联合使用可减少抗生素的用量。这是克服致病微生物抗生素耐药性的有效手段。